reference/35982586

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35982586

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	2194
issn	0950-9232 1476-5594
issueIdentifier	27
pageRange	2183-2194
publicationName	Oncogene
startingPage	2183
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7d16c8abf884dd7784fdf2b3d14fdd98 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_21a30339bae3a924a4fae709a0a2f262 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f20e7683602866595d2ccbc82019d9ec http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa4b83a3427af8e54c40142fcb1d07f6
bibliographicCitation	Zhong H, Lu W, Tang Y, Wiel C, Wei Y, Cao J, Riedlinger G, Papagiannakopoulos T, Guo JY, Bergo MO, Kang Y, Ganesan S, Sabaawy HE, Pine SR. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene. 2023 Jun;42(27):2183–94. doi: 10.1038/s41388-023-02715-5. PMID: 37258742.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_311b83c69d72961f2d46e7883687dd20 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1034-649X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c3d66d09565dbc2dd6dfd19134026f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecdbb97a09ac16efc02da6c9abae007a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c48e05a4430ddc6a336755156c41d84b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6534-3376 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1626-6730 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b343048ea63c3b1812af08fe3537acb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6915-7140 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7976-303X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48f3c93477e98d8b3f0beb163f226878 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_603e130131dc4c224815e0334d091b1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5318-0277 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89fc17e8ab63a8834c0bb1be9668fa6a
date	2023-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/37258742 https://doi.org/10.1038/s41388-023-02715-5
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6325 https://portal.issn.org/resource/ISSN/0950-9232 https://portal.issn.org/resource/ISSN/1476-5594
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity
discusses	http://id.nlm.nih.gov/mesh/M0485677 http://id.nlm.nih.gov/mesh/M0301174 http://id.nlm.nih.gov/mesh/M0024891 http://id.nlm.nih.gov/mesh/M0240041
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000077192Q000235 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D000077192Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016283Q000235 http://id.nlm.nih.gov/mesh/D055758Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D011905 http://id.nlm.nih.gov/mesh/D016283Q000378 http://id.nlm.nih.gov/mesh/D059016Q000235 http://id.nlm.nih.gov/mesh/D055758Q000378 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2d8cbd07f21be8cc9f8611c26faef88e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6662 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16653 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20682

Total number of triples: 61.